Cargando…
Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403650/ https://www.ncbi.nlm.nih.gov/pubmed/37547518 http://dx.doi.org/10.1016/j.ekir.2023.05.009 |
_version_ | 1785085116475768832 |
---|---|
author | Naik, Sachin Pal, Deeksha Shukla, Shubham Kumar, Vinod Kumar, Ashwini Jha, Vivekanand Minz, Ranjana Sethi, Jasmine Bharati, Joyita Divyaveer, Smita Kumar, Vivek Rathi, Manish Kohli, Harbir Singh Ramachandran, Raja |
author_facet | Naik, Sachin Pal, Deeksha Shukla, Shubham Kumar, Vinod Kumar, Ashwini Jha, Vivekanand Minz, Ranjana Sethi, Jasmine Bharati, Joyita Divyaveer, Smita Kumar, Vivek Rathi, Manish Kohli, Harbir Singh Ramachandran, Raja |
author_sort | Naik, Sachin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10403650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104036502023-08-06 Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk Naik, Sachin Pal, Deeksha Shukla, Shubham Kumar, Vinod Kumar, Ashwini Jha, Vivekanand Minz, Ranjana Sethi, Jasmine Bharati, Joyita Divyaveer, Smita Kumar, Vivek Rathi, Manish Kohli, Harbir Singh Ramachandran, Raja Kidney Int Rep Research Letter Elsevier 2023-05-16 /pmc/articles/PMC10403650/ /pubmed/37547518 http://dx.doi.org/10.1016/j.ekir.2023.05.009 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Letter Naik, Sachin Pal, Deeksha Shukla, Shubham Kumar, Vinod Kumar, Ashwini Jha, Vivekanand Minz, Ranjana Sethi, Jasmine Bharati, Joyita Divyaveer, Smita Kumar, Vivek Rathi, Manish Kohli, Harbir Singh Ramachandran, Raja Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk |
title | Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk |
title_full | Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk |
title_fullStr | Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk |
title_full_unstemmed | Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk |
title_short | Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic Risk |
title_sort | rituximab in patients with primary membranous nephropathy with high immunologic risk |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403650/ https://www.ncbi.nlm.nih.gov/pubmed/37547518 http://dx.doi.org/10.1016/j.ekir.2023.05.009 |
work_keys_str_mv | AT naiksachin rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT paldeeksha rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT shuklashubham rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT kumarvinod rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT kumarashwini rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT jhavivekanand rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT minzranjana rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT sethijasmine rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT bharatijoyita rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT divyaveersmita rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT kumarvivek rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT rathimanish rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT kohliharbirsingh rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk AT ramachandranraja rituximabinpatientswithprimarymembranousnephropathywithhighimmunologicrisk |